期刊文献+

加味当归补血汤调节IgA肾病肾虚血瘀证患者细胞因子的临床研究 被引量:13

A clinical study on the effects of supplemented Danggui Buxue Decoction on cytokines in IgA glomerulonephritic patients of kidney deficiency and blood stasis pattern
原文传递
导出
摘要 目的研究加味当归补血汤对Ig A肾病患者的抑制细胞因子聚集及延缓肾脏纤维化的保护作用。方法将经过肾活检证实的Ig A肾病患者进行随机分组治疗,对照组仅使用基础治疗,治疗组在基础治疗的基础上加用加味当归补血汤。在治疗终点应用统计学方法分析2组患者血、尿细胞因子及纤维化相关指标,并进行组间疗效差异的比较。结果治疗组和对照组均可减少24 h尿蛋白水平,治疗组由治疗前的(5.78±1.10)g下降至(1.25±0.67)g,而对照组由(5.25±1.21)g下降至(2.09±0.89)g。同时具有调节患者细胞因子和纤维化相关指标如单核细胞趋化蛋白-1(MCP-1)、巨噬细胞移动抑制因子(MIF)、转化生长因子-β1(TGF-β1)、透明质酸酶(HA)、层粘连蛋白(LN)、胶原Ⅳ(Col-Ⅳ)、Ⅲ型前胶原N端肽P(PⅢNP)等的作用疗效显著,治疗前后自身对照改善均具有统计学意义(P<0.05)。2组治疗后以上数据的组间比较,除尿液LN外组间比较均有统计学意义,分析其在Ig A肾病肾脏纤维化的意义表明治疗组的疗效优于对照组。结论中药和西药治疗均对Ig A肾病具有较好的抑制细胞因子聚集及延缓肾脏纤维化的保护作用,配合中药加味当归补血汤治疗可以明显提高临床疗效。 Objective To investigate the effects of supplemented Danggui Buxue Tang (Chinese angelica blood-tonifying decoction)on inhibition of cytokine congregation and kidney cirrhosis in patients with IgA glomerulonephritis.Methods Histopathologically confirmed IgA grlomerulonephritic patients were ran-domly divided into two groups.Both groups received routine treatment while treatment group was given an extra supplemented Danggui Buxue Tang.Outcome measures were urine and blood cytokines and fibrosis related parameters to compare the differences between groups.Results 24h urine protein level was both reduced in treatment group (from 5.78 ±1.10 g to 1.25 ±0.67 g)and control group (from 5.25 ±1.21 g to 2.09 ±0.89 g).Cytokines and fibrosis related parameters including MCP-1,MIF,TGF-β1,HA,&amp;nbsp;LN,Col-IV,and PIIINP were all significantly improved after intervention in both groups respectively (P〈0.05).The difference between two groups was significant in all factors except LN.Conclusion Com-bined treatment of with conventional and Chinese medicine is effective for IgA glomerulonephritis in terms of inhibiting cytokine aggregation and delay kidney cirrhosis.Adding supplemented Danggui Buxue Tang according to TCMpattern identification seems to improve effectiveness significantly.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2015年第8期573-576,共4页 Journal of Beijing University of Traditional Chinese Medicine
基金 国家自然科学基金面上项目(No.81273723 No.81473633) 江苏高校优势学科建设工程项目 江苏省第二批老中医药专家学术经验继承工作项目
关键词 IGA肾病 加味当归补血汤 细胞因子 纤维化相关指标 临床研究 IgA nephropathy Danggui Buxue Decoction cytokines renal fibrosis parameters clinical study
  • 相关文献

参考文献5

  • 1王海燕.肾脏病学[M].2版.北京:人民卫生出版社,2001:637.
  • 2EFSTATHIOS A. Treatment of primary IgA nephropathy[J]. Kidney Int, 2004,65( 1) :341 -355.
  • 3陈灏珠.实用内科学[M].11版.北京:人民卫生出版社,2004.1857-1859.
  • 4TRYGGVASON K, PATRAKKA J, WARTIOVAARA J.Heraditary proteinuria syndromes and mechanisms of pro-teinuria[J]. N Engl Med, 2006,354(13) : 1387 -1401.
  • 5SCHRIJVERS BF,FLYVBJERG A, DE VRIESE AS. Therole of vascular endothelial growth factor (VEGF) in renalpathophysiology [ J ]. Kidney Int,2004,65 ( 6 ):2003 -2017.

共引文献108

同被引文献164

引证文献13

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部